Drug Trial Radar · NCT07880223
Comparison of Two Postoperative Care Strategies After Breast Surgery
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
108
Planned (sponsor's estimate)
Start
Oct 19, 2026
Primary completion
Aug 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- Moumtzidou Maria AikateriniAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 19, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to compare two postoperative analgesia strategies in adult women undergoing breast surgery and to evaluate their effects on postoperative pain and quality of recovery after hospital discharge. The main questions it aims to answer are: * Does a patient education-based analgesia strategy improve postoperative pain control compared with standard analgesic management? * Does the patient education-based strategy improve quality of recovery after hospital discharge? Researchers will compare the patient education group with the standard care group to assess differences in postoperative pain intensity and quality of recovery. Participants will: * Receive either a patient education-based postoperative analgesia strategy or standard postoperative analgesic management. * Complete questionnaires assessing pain, quality of recovery, and other aspects of health at specified time points. * Be followed for 90 days after surgery.
Conditions
- Postoperative Pain
- Pain Management
- Breast Surgery
- Chronic Postoperative Pain
Interventions
Patient EducationBehavioral
Structured patient education regarding postoperative pain management, including discussion of the analgesic strategy and appropriate use of pharmacological and non-pharmacological pain management measures.
ParacetamolDrug
Paracetamol 1 g orally three times daily (3 g/day)
DexketoprofenDrug
Dexketoprofen 50 mg is administered intravenously every 12 hours during the first 48 hours postoperatively. It is then switched to oral dexketoprofen 25 mg every 12 hours for 3 days, followed by use as needed for pain until 7-14 days after surgery.
PregabalinDrug
Pregabalin 25-75 mg is administered orally every 12 hours for 30 days as part of the multimodal postoperative analgesic regimen
TramadolDrug
Tramadol 50-100 mg IV postoperatively as rescue therapy (maximum dose 300 mg/day). If the patient received tramadol during the postoperative period, oral tramadol 50 mg was continued as needed for pain for 4-7 days (maximum daily dose 300 mg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Postoperative Pain IntensityTime frame: Postoperative day 1, day 7, 1 month, and 3 months after surgery
- Quality of RecoveryTime frame: Postoperative day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University General Hospital of Heraklion (PAGNI)
Heraklion, Crete, Greece · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.